MFSD1 is an orphan major-facilitator-superfamily transporter that localizes predominantly to lysosomes and forms a stable complex with GLMP.[@lefrancois2019][@stre2019] Unlike transporters with fully resolved substrate identity, MFSD1 is currently interpreted through phenotype-first biology: organ homeostasis defects in knockout models, lysosomal stress signatures, and altered trafficking behavior including integrin recycling changes.[@lefrancois2019][@roblek2022][@mller2023]
MFSD1 is an orphan major-facilitator-superfamily transporter that localizes predominantly to lysosomes and forms a stable complex with GLMP.[@lefrancois2019][@stre2019] Unlike transporters with fully resolved substrate identity, MFSD1 is currently interpreted through phenotype-first biology: organ homeostasis defects in knockout models, lysosomal stress signatures, and altered trafficking behavior including integrin recycling changes.[@lefrancois2019][@roblek2022][@mller2023]
Although direct neurodegeneration causality remains incompletely established, MFSD1 biology intersects mechanisms repeatedly relevant to neurodegeneration, including lysosomal competence, membrane-recycling fidelity, and inflammatory-stress adaptation.[@stre2019][@mller2023][@nixon2013]
Structural and Systems Context
MFSD1 belongs to the broad MFS transporter architecture class, with predicted multi-pass membrane topology suited for small-molecule transport across acidic intracellular organelles.[@reddy2012] Current mammalian evidence places MFSD1 in lysosomal membranes, where GLMP acts as an accessory stabilizing factor.[@lefrancois2019][@stre2019]
This MFSD1-GLMP partnership appears necessary for protein stability and compartment function, suggesting that MFSD1 should be analyzed as a transporter module rather than a single isolated protein.
Normal Function: What is High Confidence vs Emerging
High-confidence findings
MFSD1 localizes to lysosomes and physically/functionally depends on GLMP.[@lefrancois2019][@stre2019]
Genetic loss in mice causes organ-level pathology and homeostasis failure, including liver phenotypes.[@lefrancois2019][@stre2019]
Disease-Relevant Interpretation for Neurodegeneration
MFSD1 should currently be treated as a mechanistic modifier candidate rather than a validated monogenic neurodegeneration driver.
Why it still matters for brain disease models
Lysosomal dependency of vulnerable [neurons](/entities/neurons)
Long-lived neurons rely on high-fidelity lysosomal flux for proteostasis and organelle turnover. Any persistent lysosomal transporter dysfunction can amplify aggregate burden and stress signaling.[@nixon2013]
Membrane-recycling and adhesion state control
MFSD1 loss shifts integrin activation and recycling behavior in model systems.[@roblek2022] In neural tissue, analogous membrane-recycling distortions could affect neurite maintenance, glial interactions, and injury responses.
Inflammatory and metabolic cross-talk
MFSD1-linked immune and homeostatic phenotypes suggest participation in broader stress-integration circuits that are relevant to progressive neuroinflammatory states.[@mller2023][@nixon2013]
Translational Strategy and Research Gaps
Immediate priorities
Define endogenous substrate(s) and directionality of transport.
Map neuron/glia expression with region- and age-resolved atlases.
Quantify MFSD1 perturbation effects on lysosomal pH, lipid composition, and cargo flux in neural systems.
Medium-term priorities
Test whether MFSD1 perturbation modifies vulnerability in established [Parkinson's disease](/diseases/parkinsons-disease) and [Alzheimer's disease](/diseases/alzheimers-disease) cellular models.
Resolve whether MFSD1 effects are cell-autonomous (neuronal) or networked via immune/glial signaling.
Trial relevance today
MFSD1 is not yet an intervention-ready target. Its strongest near-term use is as a pathway node for stratification and mechanism testing inside lysosomal-dysfunction programs.
Evidence Quality Snapshot
High confidence: lysosomal localization and GLMP dependence.[@lefrancois2019][@stre2019]
Moderate confidence: integrin-recycling and membrane-traffic regulation role.[@roblek2022]
[MFSD1 Protein - UniProt](https://www.uniprot.org/uniprotkb/Q9NUJ1)
[OMIM: MFSD1](https://www.omim.org/entry/614521)
References
[Lefrancois S, Børud B, Sætre F, et al, The lysosomal transporter MFSD1 is essential for liver homeostasis and critically depends on its accessory subunit GLMP (2019)](https://pubmed.ncbi.nlm.nih.gov/31661432/)
[Sætre F, Sahu B, Henriksen JR, et al, The intracellular transporter MFSD1 and accessory subunit GLMP localize to lysosomes and maintain membrane protein homeostasis (2019)](https://pubmed.ncbi.nlm.nih.gov/30770430/)
[Roblek M, Bicher V, van Gogh M, et al, The Solute Carrier MFSD1 decreases the activation status of beta1 integrin and thus tumor metastasis (2022)](https://pubmed.ncbi.nlm.nih.gov/35211397/)
[Møller SH, Nylén S, Sætre F, et al, Essential role of MFSD1-GLMP-GIMAP5 in lymphocyte survival and liver homeostasis (2023)](https://pubmed.ncbi.nlm.nih.gov/38055739/)
[Nixon RA, The role of autophagy in neurodegenerative disease (2013)](https://pubmed.ncbi.nlm.nih.gov/27973478/)
[Reddy VS, Shlykov MA, Castillo R, Sun EI, Saier MH Jr, The major facilitator superfamily (MFS) revisited (2012)](https://pubmed.ncbi.nlm.nih.gov/18471006/)